[PTGX] YoY Quarter Result on 30-Sep-2017 [#Q3]

Stock
[PTGX] Protagonist Therapeutics, Inc.
Announcement Date
06-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- 67.79%
YoY- 31.89%
Quarter Report
PTGX's Result
PTGX's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
Revenue 10,286 13,114 4,141 6,117 8,781 0 0 -
PBT -33,804 -7,763 -16,511 -8,735 -4,825 -7,084 -3,449 46.23%
Tax 122 -40 -102 0 -108 0 -572 -
NP -33,804 -7,763 -16,409 -8,735 -4,825 -7,084 -3,449 46.23%
Tax Rate - - - - - - - -
Total Cost 44,090 20,877 20,550 14,852 13,606 7,084 3,449 52.85%
Ratio Analysis
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
NP Margin -328.64 -59.20 -396.26 -142.80 -54.95 0.00 0.00 -
Per Share
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
EPS -0.70 -0.21 -0.61 -0.38 -0.29 -0.84 -0.59 2.88%
EPS Diluted -0.70 -0.21 -0.61 -0.38 -0.29 -0.84 -0.59 2.88%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.